Difference between revisions of "File:FlattenedRoundPills.jpg"
From Self-sufficiency
m (1 revision from commons:File:FlattenedRoundPills.jpg) |
m |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
== {{int:filedesc}} == | == {{int:filedesc}} == | ||
− | Round, biconvex white tablets, photographed by [[:en:User:Slashme|David Richfield]] | + | Round, biconvex white tablets, photographed by [[:wikipedia:en:User:Slashme|David Richfield]] |
== {{int:license}} == | == {{int:license}} == | ||
Line 6: | Line 6: | ||
[[Category:Pills]] | [[Category:Pills]] | ||
− |
Latest revision as of 18:56, 24 September 2010
Summary
Round, biconvex white tablets, photographed by David Richfield
Licensing:
|
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 18:56, 24 September 2010 | 2,048 × 1,536 (117 KB) | Jontas (Talk | contribs) |
- You cannot overwrite this file.
File usage
More than 100 pages link to this file. The following list shows the first 100 page links to this file only. A full list is available.
- 4-Hydroxy-4-methylpentanoic acid
- ADX-47273
- AEZS-108
- Acetasol
- Actovegin
- Acunol
- Alferon N
- Androgen replacement therapy
- Antibody-drug conjugate
- Anticachexia
- Antipyrine and benzocaine ear drops
- Ataractive
- Binding coefficient
- Biological target
- Biopharmaceutics Classification System
- Bolus (medicine)
- British Approved Name
- CCG-4986
- CPCCOEt
- Calcimimetic
- Certain safety factor
- Chemogenomics
- Clark's rule
- Clinical investigator
- Clinical pharmacology
- Clinical site
- Competitive antagonist
- Compound spirit of ether
- Context-sensitive half-life
- Controlled substance
- Detoxication
- Diazaborine
- Dirty drug
- Distribution (pharmacology)
- Donnatal
- Dosage form
- Dose concentration
- Drug Identification Number
- Dynepo
- EC50
- Embeda
- Equagesic
- Ethnopharmacy
- Eye drop
- Fine chemicals
- GS-39783
- GW 501516
- Galactagogue
- Haemaccel
- Inosea
- Investigational product
- Loading dose
- Loewe additivity
- MPPF
- Maxflu
- Mechanism of action
- Median toxic dose
- Metanx
- Murphy drip
- Nasal spray
- National Medicinal Drugs Policy
- Norepinephrine bitartrate
- Oral administration
- Oralin
- PHCCC
- Pharmaceutical codes
- Pharmaceutical glaze
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacological Calvinism
- Pharmacological gene therapy
- Pharmacometrics
- Pharmacoperone
- Pharmacotherapy
- Pharmacotoxicology
- Phenyltriazine
- Phospholipidosis
- Phytopharmacology
- Pill dispenser
- Potency (pharmacology)
- Prescription cascade
- Promegapoietin
- Protective index
- Provocation test
- Psorizide Forte
- Psychotomimetic
- Rate of infusion
- Route of administration
- Selective receptor modulator
- Sialogogue
- Specol
- TCH346
- Tablet
- Targeted drug delivery
- Therapeutic Targets Database
- Time Release Technology (medicine)
- Transdermal patch
- Universal antidote
- Vasoactive
- Vasopressin analogue